Journal of Bacteriology, July 1999, p. 4308-4317, Vol. 181, No. 14
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Chemotactic Response of Vibrio
anguillarum to Fish Intestinal Mucus Is Mediated by a Combination
of Multiple Mucus Components
Ronan
O'Toole,1,*
Susanne
Lundberg,2
Sten-Åke
Fredriksson,2
Anita
Jansson,2
Bo
Nilsson,2 and
Hans
Wolf-Watz1
Department of Cell and Molecular Biology,
Umeå University, S-901 87 Umeå,1 and
Department of NBC Defence, National Defence Research
Establishment, S-901 82 Umeå,2 Sweden
Received 23 November 1998/Accepted 20 April 1999
 |
ABSTRACT |
Chemotactic motility has previously been shown to be essential for
the virulence of Vibrio anguillarum in waterborne
infections of fish. To investigate the mechanisms by which chemotaxis
may function during infection, mucus was isolated from the intestinal and skin epithelial surfaces of rainbow trout. Chemotaxis assays revealed that V. anguillarum swims towards both types of
mucus, with a higher chemotactic response being observed for intestinal mucus. Work was performed to examine the basis, in terms of mucus composition, of this chemotactic response. Intestinal mucus was analyzed by using chromatographic and mass spectrometric techniques, and the compounds identified were tested in a chemotaxis assay to
determine the attractants present. A number of mucus-associated components, in particular, amino acids and carbohydrates, acted as
chemoattractants for V. anguillarum. Importantly, only upon combination of these attractants into a single mixture were levels of
chemotactic activity similar to those of intestinal mucus generated. A
comparative analysis of skin mucus revealed its free amino acid and
carbohydrate content to be considerably lower than that of the more
chemotactically active intestinal mucus. To study whether host
specificity exists in relation to vibrio chemotaxis towards mucus,
comparisons with a human Vibrio pathogen were made. A
cheR mutant of a Vibrio cholerae El Tor strain
was constructed, and it was found that V. cholerae and
V. anguillarum exhibit a chemotactic response to mucus from
several animal sources in addition to that from the human jejunum and
fish epithelium, respectively.
 |
INTRODUCTION |
Vibrio anguillarum is an
important pathogen of marine fish species, being the major causative
agent of a terminal hemorrhagic septicemia known as vibriosis (9,
28). In intensive aquaculture, outbreaks of vibriosis can
severely deplete fish stocks (2) and hence, much effort is
being directed towards understanding the events behind the pathogenic
process of vibriosis. The modes of transmission of Vibrio
fish pathogens have been determined to be waterborne (23)
and foodborne (48) infection. A number of factors have been
implicated in the virulence of V. anguillarum, including the
iron-sequestering system (6, 7, 50), hemolytic and
proteolytic extracellular products (22, 35, 55),
lipopolysaccharide (38), and serum resistance
(56). Like other members of the Vibrio genus,
V. anguillarum exhibits rapid swimming motility in an
aqueous milieu which is conferred by a polar flagellum. Previously, our
laboratory revealed that chemotactic motility mediated by the polar
flagellum is essential for virulence when fish are exposed to the
pathogen by immersion in bacteria-containing water but not by
intraperitoneal injection (42). It was subsequently considered important to elucidate possible mechanisms by which chemotactic motility is involved in the virulence of V. anguillarum.
The virulence findings imply that V. anguillarum responds
chemotactically to certain fish-derived products in a manner that promotes the infection process prior to penetration of the fish epithelium. Different lines of evidence indicate that V. anguillarum can invade fish epithelium at more than one site,
including the skin and the intestinal tract (10, 54). The
skin is directly exposed to water containing the pathogen, and it has
been shown that V. anguillarum adheres to skin mucus
(4, 27) and can invade through experimentally created
lesions on the skin (54), which suggests that this is a
plausible route of infection in the case of injured fish. Furthermore,
marine teleosts, in contrast to their freshwater counterparts, are
known to continuously drink water (11), which would hence
subject the gastrointestinal tract to waterborne infection. It has been
demonstrated that orally ingested V. anguillarum can survive
passage through the stomach of feeding fish (41) and that
the intestinal tract is a site of adhesion (20, 40),
colonization, and proliferation (41) for V. anguillarum whereby it can utilize intestinal mucus as a nutrient
source (15, 39). In addition, oral or rectal administration of V. anguillarum to fish results in a systemic infection
(17, 40) in which V. anguillarum is transported
across the intestinal epithelium by endocytosis (17). Given
that the fish skin and intestinal epithelial surfaces are protected by
a layer of mucus, to invade the epithelium, disseminate within the
host, and manifest vibriosis, V. anguillarum must first
negotiate its way through the mucus barrier. To achieve such a feat, it
became apparent that V. anguillarum may direct its passage
towards and through mucus by using chemotactic motility whereby
components of the mucus act as chemoattractants.
The primary objective of this study was to measure the chemotactic
response of V. anguillarum to mucus from a natural host of
vibriosis and to investigate the basis of any response with respect to
mucus composition. The response of V. anguillarum wild type
and a nonchemotactic mutant to mucus from rainbow trout was quantified
in a chemotaxis assay. Biochemical analysis was performed on intestinal
mucus to determine the nature of the chemoattractant(s) present, and
comparative studies with skin mucus were made. We also examined whether
another Vibrio pathogen, Vibrio cholerae, exhibited a chemotactic propensity specifically towards mucus from its
preferred site of colonization, the human jejunum, in contrast to mucus
from other animal sources. An open reading frame corresponding to the
cheR homologue of V. cholerae was cloned and
mutated to aid this investigation.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
V. anguillarum NB10
(serotype O1) was isolated at the Umeå Marine Research Center,
Norrbyn, Sweden, by our laboratory during a natural outbreak of
vibriosis (37). V. anguillarum nonchemotactic mutant OTR27 was derived from strain NB10 following construction of a
411-bp in-frame deletion in the coding region of the cheR gene (42). OTR27 was complemented with wild-type
cheR by homologous recombination of the suicide vector
pNQ705.1 (31) containing the wild-type cheR gene
of V. anguillarum (plasmid pCheR-Va) into the truncated
cheR gene of OTR27. The resulting strain, OTR27/pCheR-Va, regained chemotactic motility in liquid broth and soft agar. V. cholerae CVD110
(ctxAB zot ace)
hlyA::(ctxB mer) Hgr
(32) is an attenuated derivative of O1 El Tor strain E7946 (29). Escherichia coli DH5
(Pharmacia) was
used as a host strain for cloning experiments with pBluescript KS(+)
(Stratagene). For the cloning of DNA fragments into pNQ705.1
(31), ligation products were transformed into the highly
competent E. coli SY327 (34). pNQ705.1
recombinants to be conjugated into Vibrio strains were then
transformed into E. coli S17-1 (49), which was
used as the donor strain.
Media and growth conditions.
E. coli was routinely
grown at 37°C with Luria broth or agar (Bacto Laboratories). V. anguillarum and V. cholerae were grown at room
temperature and at 37°C, respectively, in Trypticase soy broth (TSB)
(BBL) or on TSB plus 1.5% agar. The soft agar used for assaying the
motility of Vibrio strains was TSB plus 0.3% agar. The
Vibrio-selective medium used was TCBS agar (Difco
Laboratories). Antibiotic concentrations for E. coli strains
were 100 µg of ampicillin/ml and 25 µg of chloramphenicol/ml. For
V. anguillarum and V. cholerae, 10-µg/ml
chloramphenicol was used.
Chemicals.
Types II (crude) and III (partially purified)
porcine gastric mucin, porcine and bovine bile, and all compounds
tested in the chemotaxis assay or used for analytical purposes were
purchased from Sigma Chemical Co. In all experiments, glass-distilled
deionized water was used. Solvents used for organic extraction of mucus and in thin-layer chromatography (TLC) were of analytical grade. Solvents used for other chromatographic analyses and mass spectrometry (MS) were of high-performance liquid chromatography (HPLC) grade.
PCR, DNA sequencing, and enzymes.
Oligonucleotide primers
were synthesized with an Applied Biosystems model 394 automated DNA-RNA
synthesizer (Perkin-Elmer). Unless stated otherwise, PCR cycle times
and gel electrophoretic analysis of the products were as previously
described (42). For DNA sequencing, the Applied Biosystems
Prism dye terminator cycle sequencing kit and sequencer model 377 (Perkin-Elmer) were used. Taq DNA polymerase and restriction
enzymes were purchased from Boehringer Mannheim. T4 DNA ligase was
purchased from Promega. KGB buffer (46) was used for all
restriction digests.
Isolation of rainbow trout mucus and bile.
Rainbow trout
(Oncorhynchus mykiss) weighing between 200 and 300 g
were heavily anesthetized with tricaine methane sulfonate (Sigma
Chemical Co.). The surface of each fish was rinsed with water, and the
skin mucus was collected with a plastic spatula. The mucus from up to
12 fish was combined and stored at
20°C. For the collection of
intestinal mucus, fish that had been kept in 10°C water without food
for at least 4 weeks were used to ensure that virtually all of the food
present in the gastrointestinal tract had been processed. The
peritoneum of each fish was cut open sufficiently to expose the
gastrointestinal tract. The intestine from the pylorus to the vent was
removed and its outer surface was carefully cleaned of its layers of
fat. Pressure was applied to the sides of the intestine so that the
mucus exuded out through one of the open ends. The mucus was collected
in sterile 1.5-ml polypropylene tubes, and any samples which contained
traces of blood were discarded. The intestinal mucus from up to 12 fish (2 to 4 ml in total) was combined and stored at
20°C. For the chemotaxis assays, the crude skin and intestinal mucus gel was diluted
1/10 with water and homogenized by using a Potter-Elvehjem homogenizer
and vortex shaker. Bile was obtained by inserting a fine sterile needle
attached to a 0.5-ml syringe into the gall bladders of dissected fish
and by slowly drawing out the bile, which was then stored at
20°C.
Human intestinal mucus was a generous gift from Silvia Melgar
(Department of Immunology, Umeå University) and was obtained as M199
tissue culture medium (plus dithiothreitol) washings of biopsy samples
of human jejunum that had been rinsed of fecal material.
Chemotaxis assay.
A modification of the quantitative
capillary assay (1) was used to measure Vibrio
chemotaxis. Strains of V. anguillarum and V. cholerae were grown in TSB overnight. In the case of V. cholerae, the overnight culture was diluted 10-fold in TSB and reincubated for up to 4 h to maximize the number of motile cells before proceeding to the assay. The bacteria were harvested by centrifugation at 6,000 × g for 5 min and resuspended
in an equal volume of sterile 0.9% NaCl. This washing step was
repeated three times, and the final resuspension was made in 1×
chemotaxis (CTA) buffer, i.e., 10 mM sodium phosphate buffer (pH 7.0),
to give an estimated cell density of 1010 bacteria/ml.
Serial 10-fold dilutions of the bacterial suspension were made in 1×
CTA buffer, and viable cell plating was performed. A suspension of
bacteria in 1× CTA buffer at an estimated concentration of
107 viable bacteria/ml was dispensed in 200-µl aliquots
into 1.5-ml polypropylene tubes. A 1-µl capillary tube (Drummond
Scientific Co.), heat sealed at one end and containing the substrate
(in 1× CTA buffer) to be tested in half the length of the tube, was inserted horizontally into the polypropylene tubes lying on their sides
to approximately 0.5 cm below the surface of the bacterial solution.
After incubating for 60 min at room temperature, the capillaries were
removed and externally rinsed with water, and their contents were
expelled into 300 µl of phosphate-buffered saline. Counts of viable
cells were performed on the capillary contents. In each experiment,
substrates were simultaneously tested in duplicate, and control
capillaries containing 1× CTA buffer were included. The chemotactic
activity of a particular substrate was expressed in terms of the
relative response (RR), i.e., the ratio of mean accumulation of
bacteria in substrate-containing capillaries to the mean accumulation
of bacteria in the control capillaries. For direct comparison of
bacterial accumulation in terms of cell numbers in assays where more
than one bacterial strain was tested, slight deviations in the
concentration of the bacterial suspension from the predicted
concentration of 107 viable cells/ml were adjusted for with
regard to each strain. Rainbow trout mucus was tested as a homogenate
of crude mucus gel diluted 1/10. Commercial preparations of individual
compounds were tested at the concentrations 0.1 and 1 mM and also at 10 mM for amino acids and carbohydrates. Commercial preparations of mucin
and bile were tested in the range of 0.1 to 10 mg/ml.
Fractionation methods.
The intestinal mucus homogenate
(crude mucus gel diluted 1/10 corresponding to a dry weight of 15 mg/ml) was extracted with 2.5 volumes of chloroform-methanol (2:1
[vol/vol]). The mix was extensively shaken overnight by using a
Griffin flask shaker and then allowed to separate into an aqueous and
an organic phase. The aqueous phase was reextracted by using the
organic phase from a chloroform-methanol-water (10:5:2 [vol/vol/vol])
system in which the subsequent extraction times were reduced to 1 h. In total, four extractions were made. The organic phases were
combined, thus producing two fractions, an aqueous fraction (LE-Aq) and an organic fraction (LE-Org). For chemical analyses, the material was
kept in methanol.
Analytical methods. (i) TLC.
For TLC analyses, plates coated
with silica gel 60 (Merck & Co., Inc.) were used. Samples were
evaluated by developing in chloroform-methanol-water (75:25:3
[vol/vol/vol]). To visualize the material, different spraying
reagents were used, since the sensitivity of nonspecific reagents, such
as iodine vapor, was too low. Most lipids could be seen after spraying
with n-(1-naphthyl)-ethylenediamine dihydrochloride (NEA)
(5) and heating for 10 min at 110°C. To locate
phospholipids and long-chain hydrocarbons, the plates were sprayed with
the phosphate-group-specific molybdenum blue reagent (60)
and left at room temperature. Using this procedure, phospholipids
appeared as blue spots after 5 min, and neutral lipids appeared as
white spots on a grey background after approximately 15 min. To screen
for amino acids, fractions were developed in n-butanol-acetic acid-water (100:7:5 [vol/vol/vol]) and
visualized using ninhydrine. Amino acids could be preliminarily
identified and quantified by comparing them with amino acid standards
of known concentrations.
(ii) GC and GC-MS.
A 5972 MSD gas chromatography-MS (GC-MS)
system (Hewlett-Packard) was used for the identification of compounds
present in the extracts. Quantification of identified compounds was
performed with a 5880 GC system (Hewlett-Packard) using flame
ionization detection. Both instruments were equipped with a 7673 autosampler and a DB5 column (30-m length, 0.25-mm internal diameter,
0.25-µm film thickness; J&W Scientific) with helium as the carrier
gas. Samples were introduced by splitless injection. After 1 min at 50°C, the column temperature was increased at a rate of 25°C/min to
170°C followed by 5°C/min to 280°C. The final temperature was held for 10 min. The injector temperature was 200°C and the
detector-interface temperature was 280°C. The MS was operated in the
electron ionization mode, and the acquired mass spectra were matched to
those in the NBS-Wiley database integrated with the MS software.
Free fatty acids (FA) were identified and quantified in the mucus
organic extract as their corresponding methyl ester derivatives (33). Cholesterol and mono- and diglycerides could be
identified and quantified without derivatization. Carbohydrates were
analyzed directly in the crude mucus gel as peracetylated alditol
derivatives (47). To determine the presence of both free and
bound carbohydrates, analysis was performed before and after hydrolysis
of the mucus in 4 M trifluoroacetic acid at 100°C for 4 h.
Amino acids were analyzed in the crude mucus gel after derivatization
with isobutyl chloroformate (57). As above, qualitative and
quantitative analyses were performed using the 5972 MSD GC-MS and 5880 GC systems (Hewlett-Packard), respectively. A spectrum database was
created by analyzing derivatized amino acid standards. The samples were
introduced by splitless injection into a DB1701 column (30-m length,
0.25-mm internal diameter, 0.25-µm film thickness; J&W Scientific).
The temperature was increased from 50°C to 190°C at a rate of
30°C/min and then to 280°C at a rate of 10°C/min. The final
temperature was held for 10 min.
(iii) Liquid chromatography electrospray MS (LC-MS).
The
mucus organic extract was separated by HPLC using a reversed-phase
Grom-Sil ODS4-HE column (10-cm length, 1.0-mm internal diameter; Grom
Analytic). A Rheos 4000 HPLC pump (Crelab Instruments, AB, Karlskoga,
Sweden) was used at a flow rate of 400 µl/min. A flow splitter,
installed before the sample injection valve (Valco Instruments Co.),
reduced the flow rate to 30 µl/min. Mobile phase A was methanol-water
(4:1 [vol/vol]), 5 mM ammonium acetate, and mobile phase B was
methanol-chloroform (1:1 [vol/vol]), 5 mM ammonium acetate. A linear
gradient from 100% A to 100% B over 10 min was applied 1 min after
injection, followed by 5 min at 100% B. Bile acids were analyzed by
using a gradient from acetonitrile-water (1:1 [vol/vol]) to 100%
acetonitrile containing 0.05% trifluoroacetic acid. The separated
material was introduced via a fused silica transfer line (75-µm
internal diameter) to the electrospray source. An Autospec orthogonal
acceleration-time-of-flight (TOF) unit (Micromass Ltd.) was used and
the instrument was operated at an acceleration voltage of +4 kV and
4
kV in the positive and negative ion modes, respectively. The magnetic
sector was bypassed, and the TOF analyzer was used to acquire mass
spectra over the range of 1 to 2,000 at a resolution of 1,000. For
analysis in the positive and negative ion modes, 10 mM ammonium acetate
and 0.1% ammonium hydroxide, respectively, were added to the
solutions. The sampling cone voltage was set at 50 V as a compromise
between the optimal values for different compounds. Cone voltage
fragmentation (CVF), i.e., fragmentation of compounds in the ion
source, was induced by increasing the sampling cone voltage to 150 V.
For liquid chromatography tandem MS (LC-MS-MS) analysis, the parent ion
was isolated by the magnetic sector analyzer and admitted to the
collision cell. Methane was used as the collision target at a pressure
of 1.5 × 10
4 Pa and a collision energy of 400 eV.
Product ion spectra were acquired by the TOF analyzer by summing
spectra during a 2-s interval. In the negative ion mode, the FA
composition of phospholipid species could be established from the
abundant carboxylate anions produced as previously described
(26).
Construction of a nonchemotactic mutant of V. cholerae.
A large set of primers used previously for the
sequencing and manipulation of the cheR gene of V. anguillarum (42) were paired in numerous combinations.
PCR was then performed on V. cholerae CVD110 and V. anguillarum NB10 (as a control) by using the collection of
convergent primers and the following PCR cycle times: 94°C for
30 s, 50°C for 45 s, and 72°C for 45 s. Primer pairs
producing single PCR products from V. cholerae CVD110 which correlated closely in size with the corresponding fragments obtained for V. anguillarum NB10 were retested under the same
conditions. One PCR fragment, cheRF2R2, generated from CVD110 template
was identical in size to the corresponding cheRF2R2 fragment from V. anguillarum which encompasses nearly the entire
cheR coding region. The cheRF2R2 fragment obtained from
CVD110 was cloned into the SacI and XbaI
restriction sites of pBluescript, and both strands were sequenced to
determine whether it aligned with the cheR gene of V. anguillarum at the nucleotide and deduced amino acid levels.
Another PCR fragment generated from CVD110 template, cheRF3R3, which
was similar in size to the corresponding internal cheRF3R3 fragment
from the V. anguillarum cheR gene, was cloned into the ClaI and XbaI restriction endonuclease sites of
the suicide vector pNQ705-1. The resulting recombinant plasmid,
pRON131, was sequenced with respect to its insert to verify its
identity to internal sequence of cheRF2R2 from V. cholerae.
pRON131 was mobilized by conjugal mating into V. cholerae
CVD110 as previously described (43), and conjugants were
selected on TCBS agar containing chloramphenicol. Insertion of this
plasmid by homologous recombination in the putative cheR
gene of CVD110 was verified by PCR using a primer complementary to the
plasmid just outside the linker region of pNQ705-1 and another primer
complementary to the V. cholerae cheR sequence outside the
cheRF3R3 region. The resulting V. cholerae strain, OTL131,
was tested for chemotactic motility in liquid broth and soft agar. The
two primers which generated fragment cheRF2R2 in the PCR were cheRF2
(5'-CTAGGAGCTCGCTATAACTATAAGCGATCAA) and cheRR2 (5'-CTAGTCTAGAGTTTATAAATGATGCCAGGG). The two PCR primers
which generated fragment cheRF3R3 were cheRF3
(5'-CTAGATCGATTCTTCAGGTCAAGAGCCTTAC-3') and cheRR3
(5'-CTAGTCTAGAACGTTACGACAGAAAATAAT-3'). Database searches were conducted by using the sequence analysis software of the Genetics
Computer Group, University of Wisconsin (8), and other programs available from the National Center for Biotechnology Information (35a).
Nucleotide sequence accession number.
The V. cholerae DNA sequence present on fragment cheRF2R2 described above
represents a partial sequence of the putative cheR gene of
V. cholerae and has been deposited into GenBank under the
accession no. AF139167.
 |
RESULTS |
Chemotactic response of V. anguillarum to fish
mucus.
A large accumulation (RR, 142) of wild-type V. anguillarum cells in capillaries containing the intestinal mucus
homogenate was observed with respect to the control capillaries
containing CTA buffer (Fig. 1). A
comparatively weaker chemotactic response by wild-type V. anguillarum towards skin mucus was detected (RR, 45; Fig. 1). The
motile nonchemotactic cheR mutant OTR27 was isolated from
the mucus-containing capillaries in dramatically reduced numbers, while
complementation of OTR27 with the cheR gene restored the
wild-type chemotactic phenotype (Fig. 1).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Chemotactic response of V. anguillarum to
rainbow trout intestinal and skin mucus. Chemotaxis was measured in a
capillary assay for V. anguillarum NB10 (wild type), OTR27
(cheR), and complemented strain OTR27/pCheR-Va (cheR/pCheR-Va) and was
expressed in terms of a relative response (the ratio of bacterial
accumulation in substrate-containing capillaries to that in control
buffer-containing capillaries). Mucus substrates consisted of a
homogenized 1/10 dilution of crude mucus gel. Substrates contained 1×
CTA buffer and were tested in duplicate. The accumulation of wild-type,
cheR mutant, and the complemented strain in control
buffer-containing capillaries was 102 ± 16.5, 90 ± 15, and
99 ± 10.5 viable bacteria, respectively, which correspond to an
RR of 1 for each strain. Error bars represent average deviations.
|
|
Analysis of the intestinal mucus material.
To examine the
content of intestinal mucus, the material was analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), TLC, GC,
GC-MS, and LC-MS. The compounds identified are listed in Tables
1 and 2 at
their respective concentrations in the crude mucus gel. Slight
variations in the concentrations of individual compounds in different
mucus batches were observed, and the quantities listed are average
values obtained from a number of mucus samples.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Chemotactic response of V. anguillarum to
amino acids and carbohydrates identified and quantified in rainbow
trout intestinal mucusa
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Chemotactic response of V. anguillarum to
lipids identified and quantified in rainbow trout
intestinal mucusa
|
|
(i) Protein, amino acid, and carbohydrate analyses.
The main
determinants of mucus structure are heavily glycosylated proteins known
as mucins (12). The presence of glycosylated proteins in
fish intestinal mucus was confirmed by periodic acid-Schiff staining
(53) of SDS-PAGE-separated proteins electroblotted onto
polyvinylidene difluoride membranes (data not shown). In TLC analysis,
free amino acids were visualized by using ninhydrine (Fig.
2A). GC and GC-MS determined the
identities and approximate concentrations of the amino acids in the
crude mucus gel. Seventeen of the 20 common amino acids were detected
in the mucus (Table 1). (Arginine, cysteine, and methionine were not
detected.)

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 2.
TLC analysis of the fish intestinal mucus fractions
obtained after organic solvent extraction. Initial compositional
analysis of the rainbow trout intestinal mucus was performed by TLC.
Fractions LE-Aq (aqueous) and LE-Org (organic) were obtained after
chloroform-methanol extraction of intestinal mucus homogenate. The
mucus fractions were developed in chloroform-methanol-water (75:25:3
[vol/vol/vol]). (A) Ninhydrine staining to visualize amino acids. (B)
n-(1-naphthyl)-ethylenediamine dihydrochloride (NEA)
staining to visualize lipids. (C) Molybdenum blue reagent staining to
visualize phospholipids. Lanes: 1, LE-Aq; 2, LE-Org.
|
|
GC-MS analysis was also used to identify carbohydrates in crude mucus.
Before hydrolysis of the sample, N-acetylgalactosamine, N-acetylglucosamine, 2-deoxyribose, glucose, mannose,
ribose, xylose, and inositol appeared as free carbohydrates (Table 1). Furthermore, following hydrolysis, fucose, galactose, and increased amounts of N-acetylgatactosamine and
N-acetylglucosamine were detected.
(ii) Lipid analysis.
In addition to mucins, mucus is known to
contain various types of lipids (51, 52, 58). To analyze the
lipid content, the intestinal mucus homogenate was extracted with
chloroform-methanol, producing aqueous (LE-Aq) and organic (LE-Org)
fractions. An initial examination of the composition of the extracts
was obtained by TLC. The staining reagent NEA revealed that most of the
mucus-associated lipids localized to LE-Org (Fig. 2B). The use of
appropriate standards indicated that the upper doublet seen in the
chromatogram of LE-Org (Fig. 2B) consists of cholesterol (upper band)
and polyunsaturated FAs (lower band). Saturated FAs did not stain with
NEA but could be seen following rhodamine staining (data not shown).
Phospholipids were specifically detected in the lower part of the
chromatogram by using the phosphate-group-specific molybdenum blue
reagent (Fig. 2C). Using phospholipid standards, a phospholipid which shared mobility properties with phophatidylcholine was revealed (data
not shown).
Analysis by GC-MS confirmed the presence of cholesterol and free FAs in
LE-Org and also revealed the presence of monoglycerides (Fig.
3) and their approximate concentrations
were determined by using standards (Table 2). The diglyceride
distearoylglycerol was also detected in LE-Org. As with TLC analysis, a
significant amount of unsaturated FAs was found in LE-Org, which is
consistent with a previous report concerning fish lipid extracts
(44). Among these, arachidonic acid (FA 20:4),
eicosapentaenoic (FA 20:5), and docosahexaenoic acid (FA 22:6) were
found. Other FAs detected consisted of palmitic acid (FA 16:0), stearic
acid (FA 18:0), and oleic acid (FA 18:1).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
GC-MS analysis of the LE-Org fish intestinal mucus
fraction. LE-Org was analyzed following esterification and methylation.
Identification was achieved by comparison of the GC retention times
with those of known standards and by matching the mass spectra from MS
analysis to the NBS-Wiley database. Cholesterol, FAs,
monoacylglycerides, and squalene were detected by this procedure. The
signals appearing at 17.69 and 20.92 min correspond to amide forms of
FAs. MPG, monopalmitoylglycerol; MSG, monostearoylglycerol.
|
|
LC-MS and LC-MS-MS analysis in both the positive (ES+) and negative
(ES
) ion modes were used to further characterize the LE-Org extract
(Fig. 4A). Free FAs and phospholipids
were identified and in addition a group of polar lipids, which were not
detectable using GC-MS, were determined by LC-MS to be bile acids.
Under reversed-phase conditions, the bile acids and FAs eluted early in
the chromatogram (Fig. 4A). Phospholipids constituted the middle part
of the chromatogram, while glycerides eluted last (Fig. 4A).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
LC-MS analysis of the LE-Org fish intestinal mucus
fraction. LE-Org was separated on a reversed-phase HPLC column and
analyzed by both positive and negative ion mode electrospray MS. The
elution order of the compounds present is indicated above panel A. (A)
TIC positive mode, the total ion current trace (TIC) obtained in the
positive ion mode which represents mainly protonated (M+H)+
and ammonium adduct (M+NH4)+ molecular ions;
TIC negative mode, the TIC trace obtained in the negative ion mode
which represents mainly deprotonated (M H) molecular
ions. (B) Extracted ion chromatograms in the negative ion mode of
m/z 514 and m/z 498, corresponding to
(M H) of the bile acids TC and TCDOC, respectively. The
chromatogram was normalized to the intensity of TC. (C) Extracted ion
chromatograms in the negative ion mode of m/z corresponding
to the indicated FAs. All chromatograms were normalized to the
intensity of m/z 327, corresponding to FA 22:6. (D) PI,
extracted ion chromatogram in the negative ion mode of m/z
881, corresponding to (M H) of phosphatidylinositol
substituted with FA 16:0/22:6; PC, extracted ion chromatogram in the
negative ion mode of m/z 818, corresponding to (M H + acetate) of phosphatidylcholine substituted with FA
16:0/18:1.
|
|
By comparing their retention times with those of known standards, the
bile acids present were identified as taurocholic acid (TC) and
taurochenodeoxycholic acid (TCDOC) (Fig. 4B). Quantification of the
bile acids was performed by LC-MS using the (M
H)
, i.e.,
deprotonated molecular ion, at mass-to-charge ratios (m/z) of 514 and 498 for TC and TCDOC, respectively. It was found that TC and
TCDOC accounted for approximately 80 and 20%, respectively, of the
bile present. For comparison purposes, bile isolated directly from the
gall bladder of rainbow trout was analyzed. As with LE-Org, TC and
TCDOC were the predominant cholic acid types and were also present at a
ratio of approximately 4:1 (data not shown). The identities of the FAs,
already established by the GC-MS analysis, were confirmed by LC-MS
(Fig. 4C). In addition, eicossenoic acid (FA 20:1) was detected by
LC-MS.
The presence of phospholipids was also determined by LC-MS analysis. In
the positive ion mode under CVF conditions, choline glycerophospholipids were localized in the chromatogram by a
characteristic fragment ion at an m/z of 184 originating
from the choline moiety (data not shown). The phospholipids were
further characterized in separate LC-MS-MS experiments using ES
by
selection of the molecular ion, (M
H plus acetate)
for
choline glycerophospholipids and (M
H)
for inositol
glycerophospholipids, and recording the product ion spectrum. The peak
at 8.33 min (Fig. 4D) in the m/z 881 trace gave a product
ion spectrum with fragment ions and mass losses characteristic for
phosphatidylinositol substituted with FA 16:0/22:6 (data not shown).
Similarly, for the m/z 818 trace, the peak at 10.50 min
(Fig. 4D) was identified as phosphatidylcholine substituted with FA
16:0/18:1 (data not shown).
Chemotactic response towards individual mucus components.
Commercial preparations of compounds identified in the mucus material
were individually tested in the chemotaxis assay at the concentrations
0.1, 1.0, and 10 mM. The chemotactic responses to individual compounds
at a concentration of 1 mM are illustrated in Tables 1 and 2. Compounds
for which the relative response was consistently less than 3.0 were not
considered significant chemoattractants. Of the compounds identified in
the intestinal mucus, the amino acids glutamine, glutamic acid,
glycine, histidine, isoleucine, leucine, serine, and threonine and the
carbohydrates fucose, glucose, mannose, and xylose displayed relative
responses above 3.0 and thus represented chemoattractants for V. anguillarum (Table 1). Two lipid compounds found in LE-Org, TC and
TCDOC, also generated relative responses above 3.0 (Table 2).
Commercial preparations of the individual components identified in the
intestinal mucus were each combined at the following two
concentrations: (i) their respective concentrations in the intestinal
mucus homogenate, i.e., crude mucus gel diluted 1/10 and homogenized
and (ii) 0.1 mM. All mucus-associated attractants and in addition, all
mucus components with individual relative responses below 3.0 were
combined at the above concentrations, and the resulting mixtures were
tested in the chemotaxis assay to compare their activities with that of
the intestinal mucus homogenate. Combination of each of the mucus
attractants at a concentration of 0.1 mM produced a mixture with 95%
of the activity of the intestinal mucus (Fig.
5). Similarly, combination of the
attractants at their corresponding concentrations in the intestinal
mucus homogenate produced a mixture with 75% of the chemotactic
activity of intestinal mucus (Fig. 5). In contrast, mixtures containing
mucus components with individual RRs below 3.0 possessed less than 12%
of the activity of intestinal mucus (Fig. 5).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Chemotactic activity of combinations of components
identified in rainbow trout intestinal mucus. Chemotaxis was measured
in a capillary assay for wild-type V. anguillarum NB10 and
is expressed as a percentage of the chemotactic activity, i.e., RR, of
the intestinal mucus homogenate (crude mucus gel diluted 1/10 and
homogenized) which was set at 100%. Commercial preparations of the
individual components identified in the intestinal mucus were each
combined at the following two concentrations: (i) their respective
concentrations in the intestinal mucus homogenate (IntMuc); and (ii)
0.1 mM. The above combinations were made with all mucus-associated
attractants (Attr) and with all mucus compounds with individual
relative responses below 3.0 (Non-Attr). The accumulation of wild-type
bacteria in control buffer-containing capillaries was 75 ± 12 viable bacteria, which corresponds to a relative response value of 1. All substrates contained 1× CTA buffer and were tested in duplicate.
Error bars represent average deviations.
|
|
Analysis of the skin mucus material.
The above results
demonstrate that intestinal mucus contains a range of chemoattractants,
the majority of these consisting of free amino acids and carbohydrates.
To enable comparisons between mucus from the intestinal and skin
epithelia, the skin mucus was similarly analyzed with respect to its
amino acid and carbohydrate composition. This analysis revealed that
the concentration of free amino acids and carbohydrates in skin mucus
is considerably lower than that in intestinal mucus. Skin mucus has a
content of chemoattractant amino acids (i.e., glutamic acid, [1.5
mM], glycine, [0.4 mM], histidine, [0.06 mM], and leucine, [0.15
mM]; glutamine, isoleucine, serine, and threonine were not detected) and carbohydrates (only fucose [0.076 mM] and mannose [0.05 mM] were detected before sample hydrolysis) lower than that of intestinal mucus (Table 1).
Cloning and mutagenesis of the putative cheR open
reading frame of V. cholerae.
PCR using the V. anguillarum cheR primers cheRF2 and cheRR2 produced an
approximately 810-bp fragment when both V. cholerae CVD110
and V. anguillarum NB10 cells were used as template. The 773 bp of V. cholerae DNA sequence (i.e., between and excluding the complementary sites of the V. anguillarum primers) over
its entire length exhibited 77.5 and 92.2% identity at the nucleotide and deduced amino acid levels, respectively, to the cheR
gene of V. anguillarum and, furthermore, showed considerable
homology to known cheR genes from other bacterial species.
The 773 bp of V. cholerae sequence represents a partial
coding sequence and encompasses nearly the entire cheR gene
with respect to cheR of V. anguillarum (828 bp;
GenBank accession no. U36378).
PCR using the V. anguillarum internal cheR
primers cheRF3 and cheRR3 produced an approximately 360-bp fragment
when both V. cholerae CVD110 and V. anguillarum
NB10 cells were used as template. To generate a V. cholerae
cheR mutant, the cheRF3R3 PCR fragment from CVD110 template was
cloned into the suicide vector pNQ705-1, generating plasmid pRON131.
Sequencing confirmed that cheRF3R3 exactly matched an internal region
of the putative V. cholerae cheR sequence present on
fragment cheRF2R2. pRON131 was mobilized into V. cholerae
CVD110 by conjugal mating, and PCR analysis verified that the plasmid
had integrated into the cheR gene homologue of CVD110. The
resulting mutant, OTL131, exhibited rapid nonchemotactic motility in
liquid broth and failed to swarm through soft agar, in contrast to
parent strain CVD110, which confirmed the involvement of this V. cholerae cheR gene homologue in chemotaxis.
Chemotactic response of V. cholerae to mucus and bile
from various sources.
The chemotactic response of wild-type and
cheR mutant strains of V. cholerae towards mucus
and bile from a number of sources was assayed. Porcine gastric mucus
and porcine and bovine bile extracts induced an accumulation of
wild-type V. cholerae in the capillaries (Fig.
6). In addition, a strong chemotactic
response by wild-type V. cholerae towards human jejunal
mucus (RR, 253) with respect to the M199 media control was observed
(Fig. 6). V. cholerae also exhibited chemotaxis towards
rainbow trout intestinal mucus (RR, 199; Fig. 6). V. anguillarum was similarly attracted to the above mucus and bile
substrates (data not shown).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 6.
Chemotactic response of V. cholerae to mucus
and bile from various sources. Chemotaxis was measured in a capillary
assay for V. cholerae CVD110 (wild type) and OTL131
(cheR mutant) and expressed in terms of an RR (the ratio of
bacterial accumulation in substrate-containing capillaries to that in
control buffer-containing capillaries). pp PGM, 10-mg/ml commercial
partially purified porcine gastric mucin; crude PGM, 10-mg/ml
commercial crude porcine gastric mucin; RTIM, rainbow trout intestinal
mucus homogenate; HJM, crude human jejunal mucus from M199 (tissue
culture media) washings of human jejunum biopsy samples. Control
capillaries containing M199 media were also included in the assay.
Bovine bile and porcine bile represent 10-mg/ml concentrations of
respective commercial preparations. All substrates contained 1× CTA
buffer and were tested in duplicate. The accumulations of wild-type and
cheR mutant in control buffer-containing capillaries were
76.5 ± 16.5 and 87 ± 7.5 viable bacteria, respectively,
which corresponds to an RR value of 1 for each strain. Error bars
represent average deviations.
|
|
 |
DISCUSSION |
In this study, the response of V. anguillarum towards
skin and intestinal mucus from rainbow trout was measured in a
chemotaxis capillary assay. It was found that wild-type V. anguillarum manifested a strong chemotactic response towards
intestinal mucus which was abolished in the cheR mutant
(Fig. 1). The response by V. anguillarum to skin mucus,
which was also dependent upon a fully intact chemotaxis machinery, was
relatively lower (Fig. 1). Work was then performed to identify the
chemoattractants present in fish mucus. Given the increasing evidence
which implicates the fish intestinal tract as being a site of
epithelial invasion by V. anguillarum (17, 40)
and the high chemotactic activity of its mucus layer (Fig. 1),
intestinal mucus was initially chosen for further analysis. The mucus
material was examined with respect to its protein, amino acid,
carbohydrate and lipid content using a variety of techniques including
SDS-PAGE, TLC, GC-MS, and LC-MS.
As expected, large glycosylated proteins, mucins, were associated with
the mucus (data not shown). Furthermore, free amino acids (Fig. 2A) and
carbohydrates were detected in the crude mucus material, while
hydrolysis of the mucus material liberated the monosaccharides fucose
and galactose and increased amounts of N-acetylgalactosamine
and N-acetylglucosamine (Table 1). This indicates that the
latter carbohydrates may be present as mucin-bound moieties in fish
intestinal mucus as is the case for mucus from other animal species
(45).
For the analysis of lipids, the mucus was extracted with
chloroform-methanol, and the resulting organic (LE-Org) and aqueous (LE-Aq) fractions were examined. The majority of the mucus-associated lipids partitioned to LE-Org (Fig. 2B and C), which was then analyzed and found to contain saturated and unsaturated free FAs, phospholipids, bile acids, cholesterol, and mono- and diglycerides (Fig. 3 and 4). The
dominant phospholipids present in mucus were identified as
phophatidylcholine and phosphatidylinositol (Fig. 4D). The bile acids
present consisted of TC and TCDOC (Fig. 4B), which is consistent with
the types of cholic acids identified in bile isolated from the gall
bladder of rainbow trout in this work and in a previous study by other
researchers (16). Bile is a regular constituent of the
intestinal tract (19) and is known to contain cholesterol
and phospholipids, in particular, phosphatidylcholine (18).
Thus, in addition to the bile acids, a number of other lipid components
of fish intestinal mucus may also have originated from the gall bladder.
Commercial preparations of the compounds identified in the mucus
material were tested individually for chemotactic activity with respect
to V. anguillarum. Of the free amino acids identified in the
intestinal mucus, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, serine, and threonine behaved as chemoattractants (Table 1). Furthermore, the carbohydrates fucose, glucose, mannose, and
xylose were chemotactic (Table 1). Of the lipid compounds identified,
the bile acids TC and TCDOC induced a weak chemotactic response (Table
2). Bile isolated directly from rainbow trout also possessed
chemotactic activity for V. anguillarum (data not shown).
By combining all individual chemoattractants identified into a single
mixture, it was possible to reconstitute a high level of chemotactic
activity similar to that present in the intestinal mucus homogenate
(Fig. 5). In contrast, when presented alone, none of the mucus
components possessed chemotactic activity equivalent to that of
intestinal mucus. Thus, rather than containing a single potent
chemoattractant, it appears that intestinal mucus consists of a range
of chemoattractants which contribute to the overall activity of the sample.
The bulk of the chemoattractants identified in intestinal mucus consist
of free amino acids and carbohydrates. The less-active skin mucus was
therefore analyzed with respect to its amino acid and carbohydrate
contents to permit comparisons between mucus from the intestinal and
skin epithelia. The concentrations of free amino acids and
carbohydrates, including those that act as chemoattractants, were found
to be considerably lower in skin mucus than in intestinal mucus. This
would provide a possible explanation for the lower chemotactic activity
observed for skin mucus.
Regarding the role of chemotaxis in the virulence of V. anguillarum, deductions can be made from what is known about
V. cholerae and other human enteropathogens, such as
Campylobacter jejuni. Upon ingestion, V. cholerae
colonizes the small intestine of humans from which it mounts its
pathogenic effects on the host (3). V. cholerae
exerts a chemotactic response towards the mucus layer which has been
correlated with the pathogen's competence in penetrating the mucus and
reaching the deep intervillous spaces (13, 14). This would
facilitate the close association between the pathogen and the mucosal
surface via pili which is considered important for both colonization of
the intestine (24) and the efficient delivery of secreted
toxins to epithelial cells (30). Thus, the decreased
movement (compared to that of the wild type) of the cheR
mutant of V. anguillarum towards fish mucus in vitro is
likely to be mirrored by an impaired ability to penetrate the epithelial mucus and come in contact with and invade the epithelial surface during infection. Such reasoning would account for the attenuated virulence seen for the cheR mutant when presented
to fish in the surrounding water (42). The ability of
C. jejuni to localize itself in the mucus lining of the
intestinal tract has also been associated with this pathogen's
requirement for chemotaxis in host colonization and virulence
(59).
A number of the fish intestinal mucus chemoattractants identified in
this study are also present as bacterial chemoattractants in the mucus
of other host species. For example, serine and fucose are
mucus-associated attractants for the human pathogens C. jejuni (21) and Pseudomonas aeruginosa
(36) and the porcine-infecting Serpulina
hyodysenteriae (25). This would imply that the
bacterial attraction to fish mucus may not be confined to fish
pathogens such as V. anguillarum and alternatively, that
fish pathogens may respond to mucus from other animal hosts. To
investigate this, the partial coding region of the cheR gene
of a V. cholerae El Tor strain was cloned and mutated.
Chemotaxis assays demonstrated that V. cholerae requires a
functional chemotactic system for movement towards mucus from its
preferred site of colonization, the human jejunum (Fig. 6).
Furthermore, V. cholerae displayed chemotaxis to mucus from
other animal sources, namely, the porcine stomach and rainbow trout
intestine (Fig. 6). Likewise, V. anguillarum exhibited a
chemotactic response to human and porcine mucus (data not shown). It is
therefore apparent that host specificity does not exist in relation to
the chemotactic response of pathogenic vibrios to mucus. In addition,
some variation in the content of the rainbow trout mucus batches was
observed in this work, and it is likely that similar variations also
occur in mucus from one fish species to another. However, the ability
of V. anguillarum to respond to a range of mucus
chemoattractants, as opposed to being dependent on the presence of one
major chemoattractant, may be beneficial to the pathogen. This would
enable V. anguillarum to respond to and penetrate mucus
despite variations in composition and thus the pathogen would not be
restricted in its capacity to infect different fish epithelia and,
indeed, different fish species, on the basis of mucus content.
Similarly, other mucophilic bacterial pathogens may overcome mucus
variations in different individuals susceptible to infection by
exploiting a range of chemotactic mucus constituents.
In conclusion, we have illustrated that chemotactic motility mediates
movement of the pathogens V. anguillarum and V. cholerae towards mucus from their respective hosts and, in
addition, to mucus from other animal sources. Analyses of fish
intestinal mucus allowed the identification of several mucus-associated
components consisting of amino acids, carbohydrates, and bile acids as
chemoattractants for V. anguillarum. Combination of the
individual mucus attractants generated mixtures with levels of
chemotactic activity similar to that exhibited by intestinal mucus. It
is proposed that the presence of multiple chemoattractants in host
mucus has implications for the relationship between chemotaxis and
bacterial virulence.
 |
ACKNOWLEDGMENTS |
The skillful assistance and technical advice provided by
Lars-Gunnar Hammarström is greatly appreciated.
This work was supported by grants from the Swedish Medical Research
Council (MFR), the Swedish Foundation for Strategic Research (SSF), the
Knut and Alice Wallenberg Foundation, and the J. C. Kempe Memorial
Foundation, Umeå University.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Cell and Molecular Biology, Umeå University, S-901 87 Umeå, Sweden.
Phone: 46-90-7852536. Fax: 46-90-771420. E-mail:
ronan.otoole{at}cmb.umu.se.
 |
REFERENCES |
| 1.
|
Adler, J.
1973.
A method for measuring chemotaxis and use of the method to determine optimum conditions for chemotaxis by Escherichia coli.
J. Gen. Microbiol.
74:77-91[Medline].
|
| 2.
|
Austin, B., and D. A. Austin.
1993.
Bacterial fish pathogens: disease in farmed and wild fish, 2nd ed.
Ellis Horwood Ltd., Chichester, England.
|
| 3.
|
Bennish, M. L.
1994.
Cholera: pathophysiology, clinical features, and treatment, p. 229-255.
In
I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. American Society for Microbiology, Washington, D.C.
|
| 4.
|
Bordas, M. A.,
M. C. Balebona,
I. Zorrilla,
J. J. Borrega, and M. A. Morinigo.
1996.
Kinetics of adhesion of selected fish-pathogenic Vibrio strains to skin mucus of gilt-head sea bream (Sparus aurata L.).
Appl. Environ. Microbiol.
62:3650-3654[Abstract].
|
| 5.
|
Bounias, M.
1980.
N-(1-naphthyl)ethylenediamine dihydrochloride as a new reagent for nanomole quantification of sugars on thin-layer plates by a mathematical calibration process.
Anal. Biochem.
106:291-295[Medline].
|
| 6.
|
Crosa, J. H.
1980.
A plasmid associated with virulence in marine fish pathogen Vibrio anguillarum specifies an iron-sequestering system.
Nature
284:566-567[Medline].
|
| 7.
|
Crosa, J. H.,
L. L. Hodges, and M. H. Schiewe.
1980.
Curing of a plasmid is correlated with an attenuation of virulence in the marine fish pathogen Vibrio anguillarum.
Infect. Immun.
27:897-902[Abstract/Free Full Text].
|
| 8.
|
Devereux, J.,
P. Haeberli, and O. Smithies.
1984.
A comprehensive set of sequence analysis programs for the VAX.
Nucleic Acids Res.
12:387-395.
|
| 9.
|
Egidius, E.
1987.
Vibriosis: pathogenicity and pathology.
Aquaculture
67:15-28.
|
| 10.
|
Evelyn, T. P. T.
1996.
Infection and disease.
Fish Physiol.
15:339-366.
|
| 11.
|
Fänge, R., and D. Grove.
1979.
The gastrointestinal tract.
Fish Physiol.
8:161-244.
|
| 12.
|
Forstner, J. F., and G. G. Forstner.
1994.
Gastrointestinal mucus, p. 1255-1283.
In
L. R. Johnson, et al. (ed.), In Physiology of the gastrointestinal tract. Raven Press, New York, N.Y.
|
| 13.
|
Freter, R., and P. C. M. O'Brien.
1981.
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice.
Infect. Immun.
34:222-233[Abstract/Free Full Text].
|
| 14.
|
Freter, R.,
B. Allweiss,
P. C. M. O'Brien,
S. A. Halstead, and M. S. Macsai.
1981.
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies.
Infect. Immun.
34:241-249[Abstract/Free Full Text].
|
| 15.
|
Garcia, T.,
K. Otto,
S. Kjelleberg, and D. R. Nelson.
1997.
Growth of Vibrio anguillarum in salmon intestinal mucus.
Appl. Environ. Microbiol.
63:1034-1039[Abstract].
|
| 16.
|
Goto, T.,
T. Ui,
M. Une,
T. Kuramoto,
K. Kihira, and T. Hoshita.
1996.
Bile salt composition and distribution of the D-cysteinolic acid conjugated bile salts in fish.
Fish. Sci.
62:606-609.
|
| 17.
|
Grisez, L.,
M. Chair,
P. Sorgeloos, and F. Ollevier.
1996.
Mode of infection and spread of Vibrio anguillarum in turbot Scophthalmus maximus larvae after oral challenge through live feed.
Dis. Aquat. Org.
26:181-187.
|
| 18.
|
Hay, D. W., and M. C. Carey.
1990.
Chemical species of lipids in bile.
Hepatology
12:6-16.
|
| 19.
|
Hofmann, A. F.
1994.
Intestinal absorption of bile acids and biliary constituents, p. 1845-1907.
In
L. R. Johnson, et al. (ed.), Physiology of the gastrointestinal tract. Raven Press, New York, N.Y.
|
| 20.
|
Horne, M. T., and A. Baxendale.
1983.
The adhesion of Vibrio anguillarum to host tissues and its role in pathogenesis.
J. Fish Dis.
6:461-471.
|
| 21.
|
Hugdahl, M. B.,
J. T. Berry, and M. P. Doyle.
1988.
Chemotactic behavior of Campylobacter jejuni.
Infect. Immun.
56:1560-1566[Abstract/Free Full Text].
|
| 22.
|
Inamura, H.,
T. Nakai, and K. Muroga.
1985.
An extracellular protease produced by Vibrio anguillarum.
Bull. Jpn. Soc. Sci. Fish
51:1915-1920.
|
| 23.
|
Kanno, T.,
T. Nakai, and K. Muroga.
1989.
Mode of transmission of vibriosis among ayu, Plecoglossus altivelis.
J. Aquat. Animal Health
1:2-6.
|
| 24.
|
Kaufman, M. R., and R. K. Taylor.
1994.
The toxin-coregulated pilus: biogenesis and function, p. 187-202.
In
I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. American Society for Microbiology, Washington, D.C.
|
| 25.
|
Kennedy, M. J., and R. J. Yancey, Jr.
1996.
Motility and chemotaxis in Serpulina hyodysenteriae.
Vet. Microbiol.
49:21-30[Medline].
|
| 26.
|
Kerwin, J. L.,
A. R. Tuininga, and L. H. Ericsson.
1994.
Identification of molecular species of glycerophospholipids and sphingomyelin using electrospray mass spectrometry.
J. Lipid Res.
35:1102-1114[Abstract].
|
| 27.
|
Krovacek, K.,
A. Faris,
W. Ahne, and I. Mønsson.
1987.
Adhesion of Aeromonas hydrophila and Vibrio anguillarum to fish cells and mucus-coated glass slides.
FEMS Microbiol. Lett.
42:85-89.
|
| 28.
|
Kusuda, R., and F. Salati.
1993.
Major bacterial diseases affecting mariculture in Japan.
Annu. Rev. Fish Dis.
3:69-85.
|
| 29.
|
Levine, M. M.,
R. E. Black,
M. L. Clements,
D. R. Nalin,
L. Cisneros, and R. A. Finkelstein.
1981.
Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: a review, p. 443-459.
In
T. Holme, et al. (ed.), Acute enteric infections in children. New prospects for treatment and prevention. Elsevier, Amsterdam, The Netherlands.
|
| 30.
|
Manning, P. A.
1991.
Molecular analysis of potential adhesions of Vibrio cholerae O1, p. 139-146.
In
T. Wadström, et al. (ed.), Molecular pathogenesis of gastrointestinal infections. Plenum Press, New York, N.Y.
|
| 31.
|
McGee, K.,
P. Hörstedt, and D. L. Milton.
1996.
Identification and characterization of additional flagellin genes from Vibrio anguillarum.
J. Bacteriol.
178:5188-5198[Abstract/Free Full Text].
|
| 32.
|
Michalski, J.,
J. E. Galen,
A. Fasano, and J. B. Kaper.
1993.
CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.
Infect. Immun.
61:4462-4468[Abstract/Free Full Text].
|
| 33.
|
Miller, L. T.
1982.
Single derivatization method for routine analysis of bacterial whole-cell fatty acid methyl esters, including hydroxy acids.
J. Clin. Microbiol.
16:584-586[Abstract/Free Full Text].
|
| 34.
|
Miller, V. L., and J. J. Mekalanos.
1988.
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.
J. Bacteriol.
170:2575-2583[Abstract/Free Full Text].
|
| 35.
|
Munn, C. B.
1980.
Production and properties of a hemolytic toxin by Vibrio anguillarum, p. 69-74.
In
W. Ahne (ed.), Fish diseases: third COPRAQ session. Springer-Verlag, Berlin, Germany.
|
| 35a.
| National Center for Biotechnology Information
Website. 13 April 1999, revision date. [Online.]
http://www.ncbi.nlm.nih.gov. [1 March 1999, last data accessed.]
|
| 36.
|
Nelson, J. W.,
M. W. Tredgett,
J. K. Sheehan,
D. J. Thornton,
D. Notman, and J. R. W. Govan.
1990.
Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis.
Infect. Immun.
58:1489-1495[Abstract/Free Full Text].
|
| 37.
|
Norqvist, A.,
Å. Hagström, and H. Wolf-Watz.
1989.
Protection of rainbow trout against vibriosis and furunculosis by the use of attenuated strains of Vibrio anguillarum.
Appl. Environ. Microbiol.
55:1400-1405[Abstract/Free Full Text].
|
| 38.
|
Norqvist, A., and H. Wolf-Watz.
1993.
Characterization of a novel chromosomal virulence locus involved in expression of a major surface flagellar sheath antigen of the fish pathogen Vibrio anguillarum.
Infect. Immun.
61:2434-2444[Abstract/Free Full Text].
|
| 39.
|
Olsson, J. C.,
A. Westerdahl,
P. L. Conway, and S. Kjelleberg.
1992.
Intestinal colonization potential of turbot (Scophthalmus maximus)- and dab (Limanda limanda)-associated bacteria with inhibitory effects against Vibrio anguillarum.
Appl. Environ. Microbiol.
58:551-556[Abstract/Free Full Text].
|
| 40.
|
Olsson, J. C.,
A. Jöborn,
A. Westerdahl,
L. Blomberg,
S. Kjelleberg, and P. L. Conway.
1996.
Is the turbot, Scophthalmus maximus (L.), intestine a portal of entry for the fish pathogen Vibrio anguillarum?
J. Fish Dis.
19:225-234.
|
| 41.
|
Olsson, J. C.,
A. Jöborn,
A. Westerdahl,
L. Blomberg,
S. Kjelleberg, and P. L. Conway.
1998.
Survival, persistence and proliferation of Vibrio anguillarum in juvenile turbot, Scophthalmus maximus (L.), intestine and faeces.
J. Fish Dis.
21:1-10.
|
| 42.
|
O'Toole, R.,
D. M. Milton, and H. Wolf-Watz.
1996.
Chemotactic motility is required for invasion of the host by the fish pathogen Vibrio anguillarum.
Mol. Microbiol.
19:625-637[Medline].
|
| 43.
|
O'Toole, R.,
D. M. Milton,
P. Hörstedt, and H. Wolf-Watz.
1997.
RpoN of the fish pathogen Vibrio (Listonella) anguillarum is essential for flagellum production and virulence by the water-borne but not intraperitoneal route of inoculation.
Microbiology
143:3849-3859[Abstract].
|
| 44.
|
Puustinen, T.,
K. Punnonen, and P. Uotila.
1985.
The fatty acid composition of 12 north-European fish species.
Acta Med. Scand.
218:59-62[Medline].
|
| 45.
|
Roussel, P.,
G. Lamblin,
M. Lhermitte,
N. Houdret,
J.-J. Lafitte,
J.-M. Perini,
A. Klein, and A. Scharfman.
1988.
The complexity of mucins.
Biochimie
70:1471-1482[Medline].
|
| 46.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 47.
|
Sawardeker, J. S.,
J. H. Sloneker, and A. Jeanes.
1965.
Quantitative determination of monosaccharides as their alditol acetates by gas-liquid chromatography.
Anal. Chem.
37:1602-1607.
|
| 48.
|
Sedano, J.,
I. Zorilla,
M. A. Morinigo,
M. C. Balebona,
A. Vidaurreta,
M. A. Bordas, and J. J. Borrego.
1996.
Microbial origin of the abdominal swelling affecting farmed larvae of gilt-head seabream. Sparus aurata L.
Aquac. Res.
27:323-333.
|
| 49.
|
Simon, R.,
U. Priefer, and A. Puhler.
1983.
A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria.
Bio/Technology
1:787-796.
|
| 50.
|
Singer, J. T.,
K. A. Schmidt, and P. W. Reno.
1991.
Polypeptides p40, pOM2, and pAngR are required for iron uptake and for virulence of the marine fish pathogen Vibrio anguillarum 775.
J. Bacteriol.
173:1347-1352[Abstract/Free Full Text].
|
| 51.
|
Slomiany, A.,
S. Yano,
B. L. Slomiany, and G. B. J. Glass.
1978.
Lipid composition of the gastric mucous barrier in the rat.
J. Biol. Chem.
253:3785-3791[Abstract/Free Full Text].
|
| 52.
|
Slomiany, A.,
Z. Jozwiak,
A. Takagi, and B. L. Slomiany.
1984.
The role of covalently bound fatty acids in the degradation of human gastric mucus glycoprotein.
Arch. Biochem. Biophys.
229:560-567[Medline].
|
| 53.
|
Strömqvist, M., and H. Gruffman.
1992.
Periodic acid/Schiff staining of glycoproteins immobilized on a blotting matrix.
BioTechniques
13:744-746[Medline].
|
| 54.
|
Thune, R. L.,
L. A. Stanley, and R. K. Cooper.
1993.
Pathogenesis of gram-negative bacterial infections in warmwater fish.
Annu. Rev. Fish Dis.
3:37-68.
|
| 55.
|
Toranzo, A. E.,
J. L. Barja,
R. R. Colwell,
F. M. Hetrick, and J. H. Crosa.
1983.
Haemagglutinating, haemolytic and cytotoxic activities of Vibrio anguillarum and related vibrios isolated from striped bass on the Atlantic coast.
FEMS Microbiol. Lett.
18:257-262.
|
| 56.
|
Trust, T. J.,
I. D. Courtice,
A. G. Khouri,
J. H. Crosa, and M. H. Schiewe.
1981.
Serum resistance and hemagglutination ability of marine vibrios pathogenic for fish.
Infect. Immun.
34:702-707[Abstract/Free Full Text].
|
| 57.
|
Wang, J.,
Z.-H. Huang,
D. A. Gage, and J. T. Watson.
1994.
Analysis of amino acids by gas chromatography-flame ionization detection and gas chromatography-mass spectrometry. Simultaneous derivatization of functional groups by an aqueous-phase chloroformate-mediated reaction.
J. Chromatogr.
663:71-78.
|
| 58.
|
Woodward, H.,
B. Horsey,
V. P. Bhavanandan, and E. A. Davidson.
1982.
Isolation, purification, and properties of respiratory mucus glycoproteins.
Biochemistry
21:694-701[Medline].
|
| 59.
|
Yao, R.,
D. H. Burr, and P. Guerry.
1997.
CheY-mediated modulation of Campylobacter jejuni virulence.
Mol. Microbiol.
23:1021-1031[Medline].
|
| 60.
|
Zweig, G., and J. Sherma.
1972.
CRC handbook of chromatography, p. 103-189.
Chemical Rubber Co. Press, Cleveland, Ohio.
|
Journal of Bacteriology, July 1999, p. 4308-4317, Vol. 181, No. 14
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.